Iraq Serialization and Traceability Compliance

Discover OneScan

Global Regulations

Icon graphic element
Labelling

Products are required to display information in writing.

Summary

Iraq regulates pharmaceutical products through the Ministry of Health and the State Company for Marketing Drugs and Medical Appliances (KIMADIA). In recent years, the Iraqi government has taken steps to strengthen medicine supply chain security and combat counterfeit pharmaceutical products through the introduction of digital verification and traceability measures.

Iraq has introduced requirements for certain medicines to carry GS1 compliant DataMatrix barcodes to enable product verification and improve traceability within the supply chain. The initiative aims to support authentication of medicines distributed through government procurement channels and licensed distributors.

Implementation of serialization requirements has been phased, with priority given to medicines supplied through public healthcare programs and government distribution networks. The system is intended to improve oversight of pharmaceutical imports and distribution within Iraq.

Labelling Requirements 

Pharmaceutical products distributed in Iraq must comply with labeling requirements defined by the Ministry of Health and approved during the product registration process.

For medicines included in traceability initiatives, the secondary packaging must include a GS1 compliant DataMatrix barcode.

The DataMatrix barcode typically contains the following elements:

  • GTIN
  • Serial Number
  • Batch Number
  • Expiry Date

These elements enable identification and verification of individual medicine packs within the supply chain.

Human readable information printed on the packaging must correspond to the encoded barcode data.

‍

Regulatory Timeline 

2017 onward
Iraq began introducing initiatives to strengthen pharmaceutical supply chain monitoring and combat counterfeit medicines.

Recent years
The Ministry of Health encouraged the use of GS1 standards and DataMatrix barcodes to improve product identification and verification.

Current Status
Serialization initiatives continue to develop, with traceability requirements focused on improving verification of pharmaceutical products within the national distribution system.

Reporting Requirements 

Operation
Data to Maintain
When to Record
Serialization
GTIN, Serial Number, Batch, Expiry
During packaging
Import Documentation
Product identifiers and shipment information
Before product import
Distribution Records
Shipment documentation and product identifiers
During supply chain transfers
Verification
Product identification through barcode scanning
At distribution or dispensing stage
Decommission
Product identifiers and removal reason
When product is destroyed or withdrawn

Companies must maintain traceability documentation to support regulatory verification and inspections.

Operational Timelines for Industry 

  • Ensure pharmaceutical products are registered with the Iraqi Ministry of Health.
  • Configure packaging systems to generate GS1 compliant DataMatrix barcodes when required.
  • Print serialized identifiers on secondary packaging.
  • Maintain supply chain documentation for imported and distributed medicines.
  • Support verification of pharmaceutical products during regulatory inspections.

Reporting Hub

Iraq does not currently operate a fully centralized national pharmaceutical traceability reporting system similar to those implemented in some other markets.

Traceability initiatives are primarily managed through the Ministry of Health and KIMADIA distribution systems, which oversee procurement and distribution of medicines to public healthcare facilities.

Pharmaceutical companies supplying medicines to Iraq must comply with product identification requirements and maintain supply chain documentation that supports product verification and regulatory inspections.

Aggregation Requirements 

Current publicly available regulatory guidance focuses primarily on unit level identification using DataMatrix barcodes.

Aggregation of packages into cases or pallets is not explicitly mandated in available guidance but may be implemented internally by manufacturers and distributors to support logistics and supply chain management.

Common Errors to Avoid 

  • Failure to comply with labeling and identification requirements defined by the Ministry of Health.
  • Incorrect configuration of DataMatrix barcode data elements.
  • Mismatch between serialized identifiers and regulatory documentation.
  • Incomplete traceability records during product distribution.

Trusted by Industry Leaders

Smooth and Successful

LSPedia didn’t just provide software; they ensured we were fully compliant. Anytime we had questions, the LSPedia team knew DSCSA inside and out and guided us step by step. That level of expertise made a huge difference during audits. Thanks to their expert team our audit was smooth and successful

Hussein Salman
Lead Pharmacist, Pioneer Pharmacy Services

Constant Commitment

LSPedia shows a constant commitment to improvement; whether it's their support or their product...they're always leveling up. The support team provides consistently thorough follow-up and clear, articulate communication. the support we receive represents a meaningful step up in service and is genuinely appreciated.

Zac Sweeny
EPCIS Data Encoder,Capital Wholesale Drug
Read All TestimonialsView Our Customers

Fill in the form for latest updates

Get in Touch

We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.

Contact Us